Dear Colleagues, Ladies and Gentlemen: It is done! Those were exciting trade fair days for all of us. From 14 – 17 November 2022, MEDICA and COMPAMED lived up to their transnationally highlighted position as leading information and communication platforms for the medical technology business and its supplier sector with a wealth of innovations and […]
If you are not happy with the results below please do another search
1807 search results for:
INTEGRA Biosciences is proud to announce that it has submitted company-wide emissions reduction targets through the Science Based Targets initiative (SBTi), with the aim of limiting global warming to 1.5 °C and achieving net zero by 2050 at the latest.
Leading-edge genomics CRO adds services for human clinical samples following venture capital investment as part of expanding biotech hub
Notable increase in participation – accompanying programme with many highlights and many prominent visitors Next week sees the return of the date marked in extra thick outline in many yearly calendars of the international health and medical technology industry: From Monday to Thursday (14 to 17 November 2022), the international leading medical trade fair MEDICA […]
Glycolipids, basically “fatty sweet” molecules, are a relatively unknown group of lipids. A new method developed by an Austrian team led by chemist Evelyn Rampler of the University of Vienna has now provided deeper insights into the functioning of certain glycolipids located on the surfaces of stem cells. The approach presented by the researchers from […]
The Peoples’ Friendship University of Russia (RUDN) biochemists have obtained a potential anti-cancer agent. The new substance pro-vokes cancer cells to commit “suicide” and at the same time does not affect healthy cells. The results are published in Molecules .
Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.
Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]
GenNext Technologies, a growth-stage company that provides instrumentation, software, and services to pharmaceutical researchers, was awarded the 2022 Grand Prize Award in the BioTools Innovator competition.
Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.